RYR2 and catecholaminergic polymorphic ventricular tachycardia: Numerous pathogenic gene variants have been identified in CPVT patients, with the RyR2-encoded cardiac ryanodine receptor/calcium release channel being the most commonly implicated, representing the predominant genetic subtype recognized as CPVT1 [5].